Back to Subject Index | Return to Arthritis & Rheumatism Table of Contents Page

B cells
autoimmune disease induction by microbial pathogens and, 458
non-Hodgkin's lymphoma, mixed cryoglobulinemia and, 1859
polyclonal, activation of, in Lyme borreliosis, 565
in RA, 381, 477, 678, 1418, 1771
SS-A/Ro 52-kd epitopes and, 990
B pocket, HLA-B39 and, in AS and JRA, 1672
B/B` protein, MHC class II genes, anti-U1 snRNP antibody and, 396
B1, B2 protein, autoimmune response to the spliceosome and, 777
B7/BB1, in RA, 649, 1863
B19 infection, parvovirus, 638, 1023, 1174
B27
gene, in occurrence of AS in twins in Finland, 381
HLA antigens in disease progression in psoriatic arthritis and, 845
in pathogenesis of spondylarthropathies, 1547
B39, HLA antigens in disease progression in psoriatic arthritis and, 845
B*3901, B*3902, HLA-B39 and, in AS and JRA, 1672
Bacilli, acid-fast, in tuberculous and foreign-body granulomatous reactions in a total knee prosthesis, 1325
Back, low, pain in, 1232, 1236
Backcrossing, in scleroderma in Tsk2 mouse, 1791
Bacteria
autoimmune disease induction and, 458
chromosome Chlamydia DNA in reactive arthritis SF, 1005
intracellular, in pathogenesis of spondylarthropathies, 1547
Yersinia enterocolitica binding of adhesin YadA to collagen, 1283
Bacterial antigens
autoimmune disease induction by microbial pathogens and, 458
Klebsiella pneumoniae-reactive T cells in blood in AS and, 1277
in pathogenesis of spondylarthropathies, 1547
Bacterial cell wall-induced arthritis, experimental, autoimmune disease induction by microbial pathogens and, 458
Bacterial DNA, in juvenile DM, 1513
Bacterial peptides, in pathogenesis of spondylarthropathies, 1547
Bacterial proteins, Yersinia enterocolitica binding of adhesin YadA to collagen and, 1283
Baker's cyst, ultrasonography of, 736, 859
BALB/c mice
antiinflammatory mechanism of adenosine regulators in, 1040
antineutrophil cytoplasmic antibodies in mice and, 1375
bone marrow transplantation in antiphospholipid syndrome, 115
Bare bone, directed knee examination, cartilage abnormalities and, 917
Basement membrane, vascular, granzyme A, perforin mRNA and, in RA synovium, 477
Basic protein
eosinophil major, in SSc, 939
myelin, autoimmune disease induction by microbial pathogens and, 458
Basic research studies, in A & R, 1019
Behavior
cognitive deficits in rheumatic diseases and, 1363
pain, in JRA, 1142
Behcet's disease
immunosuppressive drugs during pregnancy and, 1722
peripheral blood neutrophils in, 426
Benzodiazepines, in Chinese herbal medications, 614
Beta cells, autoimmunity and, 301
β chain
cytokines, early response genes and, 877
T cell receptors in RA and, 1242
β-galactosidase fusion proteins, SS-A/Ro 52-kd molecule epitopes and, 990
β1 integrin subunits, Arg-Gly-Asp (RGD) peptide, IL-1 and, in chondrocyte metalloproteinase synthesis, 1304
β2-glycoprotein 1-dependent reactivity, cross-reactivity of anticardiolipin autoantibodies with oxidized low-density lipoprotein and, 1382
BH1, human monoclonal antiphospholipid antibody and, 1068
Biallelic Cβ restriction fragment length polymorphism, T cell receptor β chain genes in RA susceptibility and, 91
Biclonal dysglobulinemia, in spinal involvement in gout, 139
Biglycan
in articular cartilage in RA, 660
in OA, 525, 660
Bilateral hip OA, bone mineral density and, 907
Bile salts, NSAID, gastrointestinal tract and, 5
Bilirubin, liver biopsy after MTX in RA and, 1194
Binding assay
to study insulin-like growth hormone 1 in OA, 413
to study Yersinia enterocolitica binding of adhesin YadA to collagen and, 1283
Biochemical markers of arthritis, monoclonal antibodies in detection of, 655
Biochemistry
α1-antitrypsin, end-stage liver disease, MTX and, 1014
cytokines, early response genes and, 877
DM and, 68, 123
quantitative bone scintigraphy in monostotic Paget's disease of bone and, 1506
RA and, 19, 151, 1031
scintigraphic abnormalities, bone turnover and, in OA, 78
in scleroderma in Tsk2 mouse, 1791
stromelysin degradation of cartilage and, 173, 1678
Biologic drugs, draft guidelines for drugs in JRA clinical trials and, 715
Biology
antineutrophil cytoplasmic antibodies in mice and, 1375
autoimmune disease induction by microbial pathogens and, 458
collagen type II in antigen-induced arthritis and, 1092
draft guidelines for drugs in JRA clinical trials and, 715
IgG receptors in autoimmune disease and, 306
insulin-like growth factor 1 in OA and, 413
in Lyme borreliosis, 565
RA and, 151, 1177, 1187, 1589, 1618
transplantation, immunosuppressive drugs during pregnancy and, 1722
Biomechanics, stromelysin degradation of cartilage and, 1678
Biopsy
in carpal tunnel syndrome due to T cell lymphomas, 1707
colon, HLA-DRB1*0404 allele and, in gold-induced enterocolitis and, 755
in complement C4 deficiency in glomerulonephritis, 1333
in giant cell arteritis, 374, 434
lesion, in spinal involvement in gout, 139
liver, 326, 1014, 1194
lung, 437, 1855
muscle, 690, 1157, 1513, 1618
nerve, 1618
in PM, 437
in RA, 242, 326, 690, 1194, 1618
renal, 242, 1333
sacroiliac joint, in AS, 499
salivary gland, E-selectin in SSc and, 406
skin, 862, 1157, 1791
synovial, 1338, 1457, 1604
synovial membrane, Chlamydia trachomatis in synovial membranes and, 1410
Bisphosphonate, tiludronate, etidronate and, in Paget's disease of bone, 851
Bladder cancer, cyclophosphamide in RA and, 1120
Black patients
HTLV-1 in PM, 690
SLE, 551, 1475
Blood
autoimmune disease induction by microbial pathogens and, 458
bone marrow fat in inflammation in sickled erythrocytes and, 1349
eosinophil major basic protein in SSc and, 939
fecal occult, NSAID, gastrointestinal tract and, 5
fetal, immunosuppressive drugs during pregnancy and, 1722
flow, cerebral, pain in fibromyalgia and, 916
Klebsiella pneumoniae-reactive T cells in, in AS, 1277
leukocyte DNA, COL2A1 gene mutations in chondrodysplasias and familial OA, 999
Blood (cont'd)
monocytes, 1046, 1832
mononuclear cells, 477
peripheral, 151
pressure, systolic, racial factors in gout and, 628
in RA, 29, 151, 477, 1046, 1194, 1418
transfusion of, red blood cell, in Lyme borreliosis, 565
Blot elution, to study autoimmune response to the spliceosome, 777
Body mass index
factors affecting bone mass and, 61
knee OA in athletes and, 539
osteoporosis in RA and, 806
Body weight
corticosteroids, pulse cyclophosphamide, plasma exchange and, in polyarteritis nodosa and Churg-Strauss syndrome, 1638
elastin, collagen degradation and, in SSc, 517
Bolus intravenous pulse cyclophosphamide, in polyarteritis nodosa and Churg-Strauss syndrome, 1638
Bone
in adjuvant arthritis in rats, 129
bare, directed knee examination, cartilage abnormalities and, 917
CPPD synovitis in rabbit OA and, 201
degradation of, 1328
density, 61, 129, 806, 907
formation, 129, 499, 902
Gla protein, 292
hydatid disease in chronic monarthritis and, 1338
joint and connective tissue ultrasonography of, 736
joint destruction in HIV infection and, 1328
juxtaarticular, 129
loss, 129, 334, 1204
marrow, 142, 384, 638
marrow cell transplantation, in experimental antiphospholipid syndrome, 115
marrow fat, in inflammation in sickled erythrocytes, 1349
mass, 61, 292, 334, 906
mineral density, 61, 292, 806, 902, 907, 1204
Paget's disease of, 851, 1506
periosteal, 129
in RA, 82, 384, 902, 1025, 1204
resorption, 902
scans, in OA, 78
scintigraphy, 1025, 1506
sialoprotein, 82
turnover, 78, 292, 1506
Bony crepitus, directed knee examination, cartilage abnormalities and, 917
Book Reviews
Acute Rheumatic and Immunological Diseases: Management of the Critically Ill Patient (Mandell, ed), 300
Autoimmune Diseases: Focus on Sjogren's Syndrome (Isenberg and Horsfall, eds), 875
Ciba Collection of Medical Illustrations. Volume 8: Musculoskeletal System, Part III: Trauma Evaluation and Management (Netter), 449
Doctor, Why Do I Hurt So Much? (Greenberg and Frank), 575
Fibromyalgia: Managing the Pain (Pellegrino), 576
Handbook of Immunopharmacology: Immunopharmacology of Joints and Connective Tissue, The, (Davies and Dingle, eds), 449
Immunomodulators in the Rheumatic Diseases (Furst and Weinblatt, eds), 150
Living with Lupus: All the Knowledge You Need to Help Yourself (Blau and Schultz), 875
Lyme Borreliosis (Axford and Rees, eds), 450
Nonsteroidal Anti-Inflammatory Drugs: Mechanisms and Clinical Uses. Second edition (Lewis and Furst, eds), 1532
Book Reviews (cont'd)
Reactive Amyloidosis and the Acute Phase Response. Balliere's Clinical Rheumatology. Vol. 8, no. 3 (Husby, ed), 1175
Rheumatoid Arthritis: Pathogenesis, Assessment, Outcome and Treatment (Wolfe and Pincus, eds), 1714
Rheumatoid Arthritis: Recent Research Advances (Smolen et al, eds), 149
Borrelia afzelii, in Lyme borreliosis, 565
Borrelia burgdorferi
autoimmune disease induction by microbial pathogens and, 458
Lyme borreliosis and, 565
in Lyme disease with DM symptoms in elderly, 1157
in pediatric Lyme arthritis in Europe, 361
Boston University Medical Center, cost of drugs in RA and, 318, 1862
Bovine studies
collagen type II in antigen-induced arthritis, 1092
IL-1 in experimental arthritis in mice and, 164
Mi-2 autoantigen in DM, 123
stromelysin degradation of cartilage, 173
Bowel disease, inflammatory, pathogenesis of, 1547
Brain
abscess of, mimicking giant cell arteritis, 1710
cognitive deficits in rheumatic diseases and, 1363
tissue, spin-spin relaxation of, in SLE, 810
Breast implants, silicone, scleroderma and, 719
British Isles Lupus Assessment Group (BILAG) index, antineutrophil cytoplasmic antibodies in SLE and, 633
Bromide, cyanogen, Yersinia enterocolitica binding of adhesin YadA to collagen and, 1283
Bronchoalveolar lavage, eosinophil major basic protein in SSc and, 939
Brown urine, bullous rash and, after hydroxychloroquine in SLE, 440
Bullous rash, brown urine and, after hydroxychloroquine in SLE, 440